Drug Prescriptions: Directions written for the obtaining and use of DRUGS.Prescription Drugs: Drugs that cannot be sold legally without a prescription.Drug Utilization: The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles.Medication Errors: Errors in prescribing, dispensing, or administering medication with the result that the patient fails to receive the correct drug or the indicated proper drug dosage.Physician's Practice Patterns: Patterns of practice related to diagnosis and treatment as especially influenced by cost of the service requested and provided.Prescriptions: Directions written for the obtaining and use of PHARMACEUTICAL PREPARATIONS; MEDICAL DEVICES; corrective LENSES; and a variety of other medical remedies.Drug Utilization Review: Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993.Drug Therapy, Computer-Assisted: Adjunctive computer programs in providing drug treatment to patients.Psychotropic Drugs: A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).ItalyPrescription Drug Misuse: Improper use of drugs or medications outside the intended purpose, scope, or guidelines for use. This is in contrast to MEDICATION ADHERENCE, and distinguished from DRUG ABUSE, which is a deliberate or willful action.Prescription Fees: The charge levied on the consumer for drugs or therapy prescribed under written order of a physician or other health professional.Primary Health Care: Care which provides integrated, accessible health care services by clinicians who are accountable for addressing a large majority of personal health care needs, developing a sustained partnership with patients, and practicing in the context of family and community. (JAMA 1995;273(3):192)Family Practice: A medical specialty concerned with the provision of continuing, comprehensive primary health care for the entire family.France: A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris.Anti-Inflammatory Agents, Non-Steroidal: Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.Retrospective Studies: Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.Cross-Sectional Studies: Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.Insurance, Pharmaceutical Services: Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products.Practice Guidelines as Topic: Directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery.Questionnaires: Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.Prevalence: The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.Risk Factors: An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Drug Costs: The amount that a health care institution or organization pays for its drugs. It is one component of the final price that is charged to the consumer (FEES, PHARMACEUTICAL or PRESCRIPTION FEES).Pharmacies: Facilities for the preparation and dispensing of drugs.Electronic Prescribing: The use of COMPUTER COMMUNICATION NETWORKS to store and transmit medical PRESCRIPTIONS.Nonprescription Drugs: Medicines that can be sold legally without a DRUG PRESCRIPTION.Medicare Part D: A stand-alone drug plan offered by insurers and other private companies to beneficiaries that receive their Medicare Part A and/or B benefits through the Original Medicare Plan. It includes Medicare Private Fee-for-Service Plans that do not offer prescription drug coverage and Medicare Cost Plans offering Medicare prescription drug coverage. The plan was enacted as the Medicare Prescription Drug, Improvement and Modernization Act of 2003 with coverage beginning January 1, 2006.Opioid-Related Disorders: Disorders related or resulting from abuse or mis-use of opioids.Inappropriate Prescribing: The practice of administering medications in a manner that poses more risk than benefit, particularly where safer alternatives exist.Drugs, Generic: Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.United StatesLegislation, Drug: Laws concerned with manufacturing, dispensing, and marketing of drugs.Formularies as Topic: Works about lists of drugs or collections of recipes, formulas, and prescriptions for the compounding of medicinal preparations. Formularies differ from PHARMACOPOEIAS in that they are less complete, lacking full descriptions of the drugs, their formulations, analytic composition, chemical properties, etc. In hospitals, formularies list all drugs commonly stocked in the hospital pharmacy.Analgesics, Opioid: Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS.Fees, Pharmaceutical: Amounts charged to the patient or third-party payer for medication. It includes the pharmacist's professional fee and cost of ingredients, containers, etc.Self Medication: The self administration of medication not prescribed by a physician or in a manner not directed by a physician.Cost Sharing: Provisions of an insurance policy that require the insured to pay some portion of covered expenses. Several forms of sharing are in use, e.g., deductibles, coinsurance, and copayments. Cost sharing does not refer to or include amounts paid in premiums for the coverage. (From Dictionary of Health Services Management, 2d ed)Drug and Narcotic Control: Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval (DRUG APPROVAL), and marketing of drugs.Drug Labeling: Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information.Prescription Drug Diversion: The transfer of prescription drugs from legal to illegal distribution and marketing networks.Pharmacists: Those persons legally qualified by education and training to engage in the practice of pharmacy.Drug Information Services: Services providing pharmaceutic and therapeutic drug information and consultation.Pharmacy Service, Hospital: Hospital department responsible for the receiving, storing, and distribution of pharmaceutical supplies.Drug Therapy: The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER.Community Pharmacy Services: Total pharmaceutical services provided to the public through community pharmacies.Polypharmacy: The use of multiple drugs administered to the same patient, most commonly seen in elderly patients. It includes also the administration of excessive medication. Since in the United States most drugs are dispensed as single-agent formulations, polypharmacy, though using many drugs administered to the same patient, must be differentiated from DRUG COMBINATIONS, single preparations containing two or more drugs as a fixed dose, and from DRUG THERAPY, COMBINATION, two or more drugs administered separately for a combined effect. (From Segen, Dictionary of Modern Medicine, 1992)Insurance Claim Review: Review of claims by insurance companies to determine liability and amount of payment for various services. The review may also include determination of eligibility of the claimant or beneficiary or of the provider of the benefit; determination that the benefit is covered or not payable under another policy; or determination that the service was necessary and of reasonable cost and quality.Patient Compliance: Voluntary cooperation of the patient in following a prescribed regimen.Anti-Bacterial Agents: Substances that reduce the growth or reproduction of BACTERIA.Insurance Benefits: Payments or services provided under stated circumstances under the terms of an insurance policy. In prepayment programs, benefits are the services the programs will provide at defined locations and to the extent needed.Pharmaceutical Services: Total pharmaceutical services provided by qualified PHARMACISTS. In addition to the preparation and distribution of medical products, they may include consultative services provided to agencies and institutions which do not have a qualified pharmacist.Medication Adherence: Voluntary cooperation of the patient in taking drugs or medicine as prescribed. This includes timing, dosage, and frequency.Substance-Related Disorders: Disorders related to substance abuse.Drug Industry: That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.Off-Label Use: The practice of prescribing or using a drug outside the scope of the drug's official approved label as designated by a regulatory agency concerning the treatment of a particular disease or condition.Pharmacy: The practice of compounding and dispensing medicinal preparations.Deductibles and Coinsurance: Cost-sharing mechanisms that provide for payment by the insured of some portion of covered expenses. Deductibles are the amounts paid by the insured under a health insurance contract before benefits become payable; coinsurance is the provision under which the insured pays part of the medical bill, usually according to a fixed percentage, when benefits become payable.Clinical Pharmacy Information Systems: Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of clinical pharmacy services.HandwritingDatabases, Factual: Extensive collections, reputedly complete, of facts and data garnered from material of a specialized subject area and made available for analysis and application. The collection can be automated by various contemporary methods for retrieval. The concept should be differentiated from DATABASES, BIBLIOGRAPHIC which is restricted to collections of bibliographic references.Pharmacoepidemiology: The science concerned with the benefit and risk of drugs used in populations and the analysis of the outcomes of drug therapies. Pharmacoepidemiologic data come from both clinical trials and epidemiological studies with emphasis on methods for the detection and evaluation of drug-related adverse effects, assessment of risk vs benefit ratios in drug therapy, patterns of drug utilization, the cost-effectiveness of specific drugs, methodology of postmarketing surveillance, and the relation between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines. (Pharmacoepidemiol Drug Saf 1992;1(1); J Pharmacoepidemiol 1990;1(1))Pharmaceutical Preparations: Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.Oxycodone: A semisynthetic derivative of CODEINE.Health Expenditures: The amounts spent by individuals, groups, nations, or private or public organizations for total health care and/or its various components. These amounts may or may not be equivalent to the actual costs (HEALTH CARE COSTS) and may or may not be shared among the patient, insurers, and/or employers.Guideline Adherence: Conformity in fulfilling or following official, recognized, or institutional requirements, guidelines, recommendations, protocols, pathways, or other standards.Cost Control: The containment, regulation, or restraint of costs. Costs are said to be contained when the value of resources committed to an activity is not considered excessive. This determination is frequently subjective and dependent upon the specific geographic area of the activity being measured. (From Dictionary of Health Services Management, 2d ed)Medicare: Federal program, created by Public Law 89-97, Title XVIII-Health Insurance for the Aged, a 1965 amendment to the Social Security Act, that provides health insurance benefits to persons over the age of 65 and others eligible for Social Security benefits. It consists of two separate but coordinated programs: hospital insurance (MEDICARE PART A) and supplementary medical insurance (MEDICARE PART B). (Hospital Administration Terminology, AHA, 2d ed and A Discursive Dictionary of Health Care, US House of Representatives, 1976)Medicaid: Federal program, created by Public Law 89-97, Title XIX, a 1965 amendment to the Social Security Act, administered by the states, that provides health care benefits to indigent and medically indigent persons.Central Nervous System Stimulants: A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.

Legalized physician-assisted suicide in Oregon--the first year's experience. (1/2434)

BACKGROUND AND METHODS: On October 27, 1997, Oregon legalized physician-assisted suicide. We collected data on all terminally ill Oregon residents who received prescriptions for lethal medications under the Oregon Death with Dignity Act and who died in 1998. The data were obtained from physicians' reports, death certificates, and interviews with physicians. We compared persons who took lethal medications prescribed under the act with those who died from similar illnesses but did not receive prescriptions for lethal medications. RESULTS: Information on 23 persons who received prescriptions for lethal medications was reported to the Oregon Health Division; 15 died after taking the lethal medications, 6 died from underlying illnesses, and 2 were alive as of January 1, 1999. The median age of the 15 patients who died after taking lethal medications was 69 years; 8 were male, and all 15 were white. Thirteen of the 15 patients had cancer. The case patients and controls were similar with regard to sex, race, urban or rural residence, level of education, health insurance coverage, and hospice enrollment. No case patients or controls expressed concern about the financial impact of their illness. One case patient and 15 controls expressed concern about inadequate control of pain (P=0.10). The case patients were more likely than the controls to have never married (P=0.04) and were more likely to be concerned about loss of autonomy due to illness (P=0.01) and loss of control of bodily functions (P=0.02). At death, 21 percent of the case patients and 84 percent of the controls were completely disabled (P<0.001). CONCLUSIONS: During the first year of legalized physician-assisted suicide in Oregon, the decision to request and use a prescription for lethal medication was associated with concern about loss of autonomy or control of bodily functions, not with fear of intractable pain or concern about financial loss. In addition, we found that the choice of physician-assisted suicide was not associated with level of education or health insurance coverage.  (+info)

Randomised controlled trial of effect of feedback on general practitioners' prescribing in Australia. (2/2434)

OBJECTIVE: To evaluate the effect on general practitioners' prescribing of feedback on their levels of prescribing. DESIGN: Randomised controlled trial. SETTING: General practice in rural Australia. PARTICIPANTS: 2440 full time recognised general practitioners practising in non-urban areas. INTERVENTION: Two sets of graphical displays (6 months apart) of their prescribing rates for 2 years, relative to those of their peers, were posted to participants. Data were provided for five main drug groups and were accompanied by educational newsletters. The control group received no information on their prescribing. MAIN OUTCOME MEASURES: Prescribing rates in the intervention and control groups for the five main drug groups, total prescribing and potential substitute prescribing and ordering before and after the interventions. RESULTS: The intervention and control groups had similar baseline characteristics (age, sex, patient mix, practices). Median prescribing rates for the two groups were almost identical before and after the interventions. Any changes in prescribing observed in the intervention group were also seen in the control group. There was no evidence that feedback reduced the variability in prescribing nor did it differentially affect the very high or very low prescribers. CONCLUSIONS: The form of feedback evaluated here-mailed, unsolicited, centralised, government sponsored, and based on aggregate data-had no impact on the prescribing levels of general practitioners.  (+info)

A comparison of three methods of setting prescribing budgets, using data derived from defined daily dose analyses of historic patterns of use. (3/2434)

BACKGROUND: Prescribing matters (particularly budget setting and research into prescribing variation between doctors) have been handicapped by the absence of credible measures of the volume of drugs prescribed. AIM: To use the defined daily dose (DDD) method to study variation in the volume and cost of drugs prescribed across the seven main British National Formulary (BNF) chapters with a view to comparing different methods of setting prescribing budgets. METHOD: Study of one year of prescribing statistics from all 129 general practices in Lothian, covering 808,059 patients: analyses of prescribing statistics for 1995 to define volume and cost/volume of prescribing for one year for 10 groups of practices defined by the age and deprivation status of their patients, for seven BNF chapters; creation of prescribing budgets for 1996 for each individual practice based on the use of target volume and cost statistics; comparison of 1996 DDD-based budgets with those set using the conventional historical approach; and comparison of DDD-based budgets with budgets set using a capitation-based formula derived from local cost/patient information. RESULTS: The volume of drugs prescribed was affected by the age structure of the practices in BNF Chapters 1 (gastrointestinal), 2 (cardiovascular), and 6 (endocrine), and by deprivation structure for BNF Chapters 3 (respiratory) and 4 (central nervous system). Costs per DDD in the major BNF chapters were largely independent of age, deprivation structure, or fundholding status. Capitation and DDD-based budgets were similar to each other, but both differed substantially from historic budgets. One practice in seven gained or lost more than 100,000 Pounds per annum using DDD or capitation budgets compared with historic budgets. The DDD-based budget, but not the capitation-based budget, can be used to set volume-specific prescribing targets. CONCLUSIONS: DDD-based and capitation-based prescribing budgets can be set using a simple explanatory model and generalizable methods. In this study, both differed substantially from historic budgets. DDD budgets could be created to accommodate new prescribing strategies and raised or lowered to reflect local intentions to alter overall prescribing volume or cost targets. We recommend that future work on setting budgets and researching prescribing variations should be based on DDD statistics.  (+info)

Does the availability of prescribed drugs affect rates of self poisoning? (4/2434)

The trends in self-poisoning rates and in rates of prescribing of the major drug groups were compared. Over the period 1981-91, barbiturate prescribing and self poisoning both fell by 80%; for antidepressants, prescribing increased by over 40% and self poisoning by 30%; for antipsychotics, both rose by 30%; for benzodiazepines, poisoning fell by 30% and prescribing by 20%. Even for analgesic drugs, which are also available over the counter, there was a correspondence between changes in self poisoning and prescribing. The availability of prescribed drugs is directly related to their use for self poisoning. Restricting the availability of these drugs is a possible preventative strategy, although further research on this is needed.  (+info)

Following advice in general practice. (5/2434)

A random sample of 521 patients to whom prescriptions had been issued in an urban general practice were investigated to see how well they followed advice about taking medicines.Most factors that have been previously reported as affecting this did not appear to do so. A very high degree of compliance was achieved and it is suggested that the key factor in this is the relationship between doctor and patient.  (+info)

Recent developments in maintenance prescribing and monitoring in the United Kingdom. (6/2434)

After a brief historical review of British drug legislation and public and governmental attitudes, this paper describes the wide range of policies and practices that have appeared since the explosion of illicit drug abuse in the 1960s. The spectrum goes from a reluctance to prescribe at all to maintenance on injectable opiates. Comparisons are made with differing attitudes to the availability of abortion in public health services. Compared with 5 years ago, about three times more methadone is being prescribed. There is a steady increase in prescriptions for injectable methadone but heroin maintenance is still rare. The "British System" permits great flexibility in the choice of opiates for maintenance. Some amphetamine-prescribing programmes also exist. Hair analysis for drugs to monitor levels of both prescribed and unprescribed drugs is a welcome and promising alternative to undignified and often misleading urine tests.  (+info)

Harm reduction in Bern: from outreach to heroin maintenance. (7/2434)

In Switzerland, harm-reduction programs have the support of the national government and many localities, in congruence with much of the rest of Europe and in contrast with the United States, and take place in public settings. The threat of AIDS is recognized as the greater harm. This paper describes the overall national program and highlights the experience from one city; the program is noteworthy because it is aimed at gathering comparative data from controlled trials.  (+info)

Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes. (8/2434)

BACKGROUND: The benefits of near-patient, point-of-care tests have not been fully examined. We have assessed the clinical, organizational, and economic outcomes of implementing a near-patient test for C-reactive protein (CRP) in general practice. METHODS: In a randomized crossover trial during intervention periods, general practitioners (GPs) were allowed to measure CRP within 3 min, using NycoCard(R) CRP. During control periods, they had to mail blood samples for CRP measurements to the hospital laboratory and received test results 24-48 h later. Twenty-nine general practice clinics participated (64 GPs), and 1853 patients were included in the study. Results were evaluated at both the level of participating GPs and the level of included patients. RESULTS: For participating GPs, the overall use of erythrocyte sedimentation rates (ESRs) decreased by 8% (95% confidence interval, 1-14%) during intervention periods, and the number of blood samples mailed to the hospital laboratory decreased by 6% (1-10%). No reduction in the prescription of antibiotics was seen. The proportion of study patients having a follow-up telephone consultation was reduced from 63% to 53% (P = 0. 0001), and patients with CRP concentrations >50 mg/L had their antibiotic treatments started earlier when CRP was measured in general practices (P = 0.0161). CONCLUSION: The implementation of the near-patient CRP test was cost-effective mainly on the basis of a reduction in the use of services from the hospital laboratory by GPs. If the implementation is followed by education and clinical guidelines, opportunities exist for additional reduction in the use of ESR and for a more appropriate use of antibiotics.  (+info)

  • And finally, she said, "chronic illness is the primary driver of ill health, and people who fill their prescriptions have a better rate of controlling their disease. (nytimes.com)
  • The more often a patient saw the doctor, the more likely the prescriptions would be filled, but medicines with high co-pays were less likely to be bought. (nytimes.com)
  • Researchers deemed a prescription potentially inappropriate if it was refilled early - within seven days of an earlier prescription for at least 30 tablets of a drug in the same class - and originated from a different physician and different pharmacy. (healthcanal.com)
  • For how long can a C-II drug prescription be filled after it is prescribed?I want to know the time period controlled drugs can filled in the pharmacy after it has been prescribed. (enotes.com)
  • In this prospective study, carried out in a tertiary care teaching private hospital, one thousand prescriptions from the hospital pharmacy were collected, classified according to anatomic therapeutic and chemical (ATC) classification. (alliedacademies.org)
  • In this prospective observational study, we collected prescriptions from the pharmacy of Kasturba Hospital, a 1650 bedded teaching, tertiary care hospital catering to the healthcare needs of South-West districts of Karnataka, Goa and Northern districts of Kerala. (alliedacademies.org)
  • A total of 1000 prescriptions were collected in the pharmacy after obtaining approval from the Kasturba Hospital Ethics Committee. (alliedacademies.org)
  • Burt, Tal 2015-08-25 00:00:00 In 2004 the Food and Drug Administration issued a warning on the risk of suicidality in children and adolescents receiving antidepressants. (deepdyve.com)
  • The goal of drug therapy is to achieve the desired therapeutic response without producing toxicity, i.e., maximizing efficacy yet minimizing untoward effects. (alliedacademies.org)
  • The act required physicians to identify themselves by name and their licensing body's registration number on prescriptions for all narcotics and other controlled substances dispensed in the province. (healthcanal.com)
  • People under age 52 were much less likely to fill their prescriptions than older people, and men slightly less likely than women. (nytimes.com)
  • This graph shows the total number of publications written about "Drug Prescriptions" by people in this website by year, and whether "Drug Prescriptions" was a major or minor topic of these publications. (umassmed.edu)
  • Below are the most recent publications written about "Drug Prescriptions" by people in Profiles. (umassmed.edu)
  • Drug Prescriptions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (umassmed.edu)
  • Traditional approach with monotherapy is successful in only 50% of instances, because multiple mechanisms are involved in the pathogenesis of most diseases, and a single drug may not interdict all offending pathways [ 1 ]. (alliedacademies.org)
  • The analysis, published online in The Annals of Internal Medicine , was conducted in Quebec, where all residents are covered by health and drug insurance. (nytimes.com)
  • The fixed drug combination used was compared with the essential drug list of World Health Organization (WHO) and other countries. (alliedacademies.org)
  • More than 191 million opioid prescriptions were dispensed to American patients in 2017-with wide variation across states. (cdc.gov)
  • When purchasing a drug under the PBS, the consumer pays no more than the patient co-payment contribution, which, as of January 1, 2017, is A$ 38.80 for general patients. (wikipedia.org)
  • TUESDAY, June 6, 2017 (HealthDay News) -- Cancer doctors who receive freebies from pharmaceutical companies are more likely to prescribe drugs produced by those companies, a new study reports. (hon.ch)
  • At the request of McCaskill, minority staff of the Committee on Homeland Security and Governmental Affairs reviewed price increases for the 5-year-period, 2012 to 2017, across the top 20 most-prescribed brand-name drugs for seniors in the Medicare Part D program. (medscape.com)
  • Prices increased for every drug on the list between 2012 and 2017. (medscape.com)
  • Although 48 million fewer prescriptions were written for the top 20 most commonly prescribed brand-name drugs for seniors between 2012 and 2017, total sales revenue resulting from these prescriptions increased by almost $8.5 billion during the same period. (medscape.com)
  • Building on the success of the 2017 price-gouging law, the Maryland Citizens' Health Initiative will be advocating for legislation in 2018 to make all expensive prescription drugs, including brand name and specialty drugs, more affordable for Marylanders. (delmarvanow.com)
  • 2018 Annual Surveillance Report of Drug-Related Risks and Outcomes - United States. (cdc.gov)
  • The National Survey on Drug Use and Health found that 9.9 million people ages 12 and older misused prescription opioids in 2018, and an estimated 2 million people had an opioid use disorder. (nsc.org)
  • The 2018 "Employee Benefits Survey" provides benchmarking data on methods used to combat escalating prescription drug costs, including cost-sharing initiatives, limits by drug type, drug access controls, and purchasing and administration initiatives. (ifebp.org)
  • Nowadays, more so than ever before, getting high doesn't have to involve a trip to the projects to ask a sketchy man on the sidewalk for drugs. (listverse.com)
  • People who take opioid pain relievers for too long or in doses too large are more at risk of developing an opioid use disorder and more likely to die of drug overdose. (nsc.org)
  • Klein refuted that he had ever given Jackson drugs beyond the doses needed for surgery. (cnn.com)
  • The database has records of over 50 million prescriptions covering 375 million doses of powerful, dangerous pharmaceuticals . (infowars.com)
  • The risk is greater if you have used this drug for a long time or in high doses, or if you are also taking a beta blocker (such as atenolol). (riteaid.com)
  • According to Stanford, she was given high doses of a steroid drug that helped contain the disease and its symptoms but which also caused her to gain more than 150 pounds over the next five years. (nbcbayarea.com)
  • The study, soon to be published in Child Welfare, the research journal of the Child Welfare League of America, spotlights the risk of pregnancy associated with multiple prescription drugs for the almost 40,000 girls ages 15 to 18 in U.S. foster care, according to lead author Dr. Hank Gardner , the CEO and principal partner of HCMS Group. (medindia.net)
  • On September 13, 2020, the White House issued an Executive Order titled "Lowering Drug Prices by Putting America First" (the Executive Order), which directed the Secretary of the US Department of Health and Human Services. (jdsupra.com)
  • The White House released a new Executive Order on September 13, 2020, related to drug prices titled "Lowering Drug Prices by Putting America First" the September Order), whose stated purpose is to address reimbursement for. (jdsupra.com)
  • The Big Picture - In the latest election year action to address politically salient concerns with high drug costs, President Trump on Sunday signed an "Executive Order on Lowering Drug Prices by Putting America First. (jdsupra.com)
  • Notably, the lobbying arm of the drug industry, the Pharmacy Research and Manufacturers of America, didn't endorse public registries . (slate.com)
  • The combination of drugs in his system that caused his death included oxycodone, hydrocodone, diazepam (Valium), temazepam (Restoril, a strong sedative), alprazolam (Xanax), and doxylamine (a sedative found in NyQuil), report Us Weekly and TMZ .com this morning. (nymag.com)
  • Products containing the opioid drugs like codeine , hydrocodone and oxycodone . (medindia.net)
  • In New York City alone, nearly 900,000 oxycodone prescriptions and more than 825,000 hydrocodone prescriptions were filled in 2009, the city's Department of Health and Mental Hygiene has reported. (forbes.com)
  • Among those calling for a change are Missouri medical associations, members of Congress from neighboring states, the White House and even Mallinckrodt Pharmaceuticals , the St. Louis-based manufacturer of oxycodone, the highly abused prescription painkiller. (nytimes.com)
  • Pharmacies input data when a patient fills a prescription for a controlled substance, such as Oxycodone. (tampabay.com)
  • Prescribing fewer opioids to be taken over a period shorter than three days in the initial prescription decreases the likelihood of chronic use , researchers wrote in the Morbidity and Mortality Weekly Report, published by the Centers for Disease Control and Prevention. (washingtonpost.com)
  • Antidepressants are the most commonly prescribed drugs in the United States, according to the Centers for Disease Control and Prevention. (foxnews.com)
  • Prescribers and dispensers should be required to enroll in and query the state's PDMP, either directly or by delegating access to office staff, when initiating a prescription for any controlled substance and at least every 3 months (quarterly) thereafter as treatment continues, consistent with the Centers for Disease Control and Prevention prescribing guidelines. (asam.org)
  • This analysis examines the share of Part D enrollees who currently have access to extended supplies of generic, brand-name, and specialty-tier drugs covered by their plan in 2020, prior to relaxation of any early-fill restrictions in response to the COVID-19 outbreak. (kff.org)
  • Global prescription drug sales should reach nearly $1 trillion by 2020, thanks in part to FDA approvals of breakthrough drugs for cancer, hepatitis C and other diseases, a new report finds. (modernmedicine.com)
  • It doesn't affect brand name, innovative "specialty drugs" that often cost $30,000 or more annually. (delmarvanow.com)
  • Right now, costs are a huge issue for people on expensive specialty drugs," said Peter B. Bach, a drug-cost expert and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center in New York. (wsj.com)
  • Statewide, painkiller prescriptions increased by six million, or from 16.6 million to 22.5 million between 2007 and 2010, according to the report. (forbes.com)
  • Perhaps this explains another survey finding: While about four in five teens said they had discussed both alcohol and marijuana use with their parents and almost one-third said they had talked with them about crack/cocaine, only between 14 percent and 16 percent said that the topic of painkiller/prescription drug abuse had ever come up. (medicinenet.com)
  • A patient can consolidate prescription charges by using a prescription payment certificate (informally a "season ticket"), effectively capping costs at £29.10 per quarter or £104.00 per year. (wikipedia.org)
  • Recent studies indicate it costs about $500 million and takes nearly 15 years to bring a new drug to market. (washingtontimes.com)
  • 84% report that out-of-pocket drug costs would be higher. (usatoday.com)
  • In addition, the restrictive drug policy -- originally designed to reduce costs -- provided only minimal savings. (washingtonpost.com)
  • The survey also sought insight into the views of adults age 50+ regarding how prescription drugs and pharmaceutical companies are regulated, whether drug companies influence politicians and health care professionals, and what can be done to help reduce the costs associated with prescription drugs. (aarp.org)
  • See KFF's research, analysis and public opinion data, as well as Kaiser Health News' journalism, related to prescription drugs and their costs. (kff.org)
  • This quick primer explains the similarities and differences among major proposals to lower prescription drug costs introduced by House Democrats, the Senate Finance Committee, and the Trump Administration as of December 2019. (kff.org)
  • This slideshow explains the similarities and differences among major proposals to lower prescription drug costs introduced by the Trump Administration, members of Congress, and the Biden campaign. (kff.org)
  • Quick Look: How Plans Are Controlling Prescription Drug Costs. (ifebp.org)
  • As prescription drug costs continue to escalate, health plan sponsors are employing a variety of methods to contain those costs. (ifebp.org)
  • Insurance Company Allegedly Artificially Inflated Drug Costs. (ifebp.org)
  • The District Court for the District of Connecticut grants in part and denies in part the complaint by plaintiff employee benefits plan participants alleging that their defendant health insurance provider artificially inflated prescription drug costs in violation of the terms of their health insurance policies governed by the Employee Retirement Income Security Act of 1974 (ERISA). (ifebp.org)
  • While the cost of prescription drug coverage varies widely, 30 percent, or the largest group of respondents, said pharmacy benefits represent between 11 percent and 15 percent of total health care costs," says Jacobs. (shrm.org)
  • This is down from last year's survey, when the largest group indicated their drug benefits made up between 16 percent and 20 percent of total health care costs. (shrm.org)
  • According to survey respondents, the most important clinical management steps they are taking to control pharmacy benefit costs are broader based than prescription drug coverage. (shrm.org)
  • Soaring drug prices are driving up healthcare costs each year, the report notes. (medscape.com)
  • McCaskill has made tackling rising healthcare and prescription drug costs a top priority in the Senate. (medscape.com)
  • In addition, McCaskill's bipartisan legislation to boost competition for generic drugs and help lower prescription costs was signed into law by Trump. (medscape.com)
  • Ideally, PBMs help to negotiate rebates and discounts for consumers, leverage competition, and help to drive down prescription drug costs . (healthline.com)
  • The Trump administration is backing a set of actions aimed at lowering prescription-drug costs, including a cap on the dollar amount that American seniors pay each year for expensive prescription drugs. (wsj.com)
  • Drug-pricing experts, including those working for public-interest groups, generally reacted well to the ideas, but they were skeptical they would have a major impact on drug costs. (wsj.com)
  • Dr. Bach said the administration needs to analyze drug companies' costs more than it currently does. (wsj.com)
  • Every other western country uses some form of analysis" of drug-research costs, he said. (wsj.com)
  • We applaud the Senate Special Committee on Aging for holding today's hearing examining ways to reduce prescription drug costs for consumers. (prnewswire.com)
  • We agree that policy changes are necessary to reduce drug costs, and that we all have a role to play in finding solutions. (prnewswire.com)
  • The most effective way to lower prescription drug costs is through increased competition in the marketplace. (prnewswire.com)
  • When real competition exists in the marketplace PBMs can most effectively negotiate with drug manufacturers to reduce drug costs. (prnewswire.com)
  • In recent years, however, new drugs to combat obesity have moved onto the market. (livescience.com)
  • Still, only five drugs (or drug combinations) have been approved by the Food and Drug Administration for the long-term treatment of obesity. (livescience.com)
  • A Napa woman who was diagnosed with lupus when she was 12-years-old and subsequently suffered from drug-induced obesity underwent a life-saving gastric bypass surgery at Stanford Hospital & Clinics about a month ago.And Stanford is now using the case of Jena Graves as an example to warn others that sometimes taking steroids to cure one problem, may lead other problems that actually can be worse. (nbcbayarea.com)
  • A Napa woman who was diagnosed with lupus when she was 12-years-old and subsequently suffered from drug-induced obesity underwent a life-saving gastric bypass surgery at Stanford Hospital & Clinics about a month ago. (nbcbayarea.com)
  • An American Medical Association survey found that 87% of responding physicians supported PDMPs because they help prescribers become more informed about a patient's prescription history. (asam.org)
  • That data was compared with a database in which drug companies report incentives provided to doctors, including meals, travel or continuing education expenses. (webmd.com)
  • They think they're not doing anything illegal because these drugs are prescribed by doctors. (kidshealth.org)
  • This is why drug companies do what they do," Schilsky said, adding that he hopes the findings will "raise awareness among doctors that they are susceptible to these influences. (hon.ch)
  • Previous research has indicated that drug company gifts can influence doctors to choose pricey brand-name drugs over cheaper generics, Mitchell said during his Saturday presentation of the study. (hon.ch)
  • The researchers chose to focus on kidney cancer and chronic myeloid leukemia because doctors can choose between one of three different drugs to treat these cancers, Mitchell said. (hon.ch)
  • They then compared those prescribing patterns against data from Open Payments, a database created under the Affordable Care Act through which drug and medical device manufacturers must disclose any payments greater than $10 to doctors or teaching hospitals. (hon.ch)
  • It turned out the payments did appear to influence doctors' choice of drug, even though the payouts tended to be small. (hon.ch)
  • Interestingly, the researchers found mixed results when they looked at direct research funding that doctors received from drug makers. (hon.ch)
  • Whatever the reasons, whether prescribing behavior by doctors or buying behavior by consumers, lack of insurance or lack of money, or the growing prevalence of generic alternatives: spending on prescription drugs, long considered recession-proof, seems to have bumped into a wall for the first time ever. (businessinsider.com)
  • Also Wednesday, a source said the Los Angeles County coroner's office has drawn up a list of doctors who treated Jackson over the years and will talk to them to determine what kind of drugs they may have prescribed the singer in the past. (cnn.com)
  • Klein is the latest in a series of Jackson associates -- including doctors, nurses, employees and friends -- to tie the singer to drugs in recent days. (cnn.com)
  • Current thinking encourages doctors to limit opioid prescriptions to just 3 days. (familydoctor.org)
  • However, no law stops doctors from prescribing the drug for whatever reason they like-and they certainly do. (slate.com)
  • But rumors build at academic conferences and journals, subtly encouraged by the manufacturers, and doctors start writing prescriptions. (slate.com)
  • Prescription drug trafficking, lack of training and communication between specialists treating the same patient, and easy access to drugs facilitated by crooked doctors, street-level drug dealers, and doctor-shopping addicts are widely blamed. (forbes.com)
  • In a petition on its website, the group says it agrees with the goal of the legislation, but argues that mandatory patient record checking, prescription reporting, and penalties for physicians who fail to do so would create undue administrative burdens for doctors. (forbes.com)
  • Most doctors like to help their patient feel better as soon as they can, and prescribing painkilling or sedative drugs are usually the most effective for that purpose at least for a little while. (infobarrel.com)
  • How do we know if they are getting multiple prescriptions from multiple doctors? (tampabay.com)
  • Doctors generally base a diagnosis of prescription drug abuse on medical history and answers to other questions. (mayoclinic.org)
  • Some of the highest prices include orphan drugs Lumizyme at $630,159 per patient in 2015, and Zolgensma at $2.1 million for a single-dose treatment in 2019. (wikipedia.org)
  • During the summer of 2019, a number of states enacted new drug price transparency laws, swelling the number of states with such laws to 11. (jdsupra.com)
  • As you can imagine, this is leading many pharmaceutical companies to question whether India is a safe and reasonable place to manufacture their drugs. (cnn.com)
  • The price increases have to do with price-gouging, the unconscionable increase in the price of a prescription drug, on the part of some pharmaceutical companies. (delmarvanow.com)
  • Pharmaceutical companies employed a similar ruse to propel sales of drugs for "off-label" indications, or uses not green-lighted by the Food and Drug Administration. (slate.com)
  • More than thirty national organizations, from the Epilepsy Foundation to the American Cancer Society, have teamed up with pharmaceutical companies to form the Partnership for Prescription Assistance. (weau.com)
  • As American waistlines have expanded, pharmaceutical companies have been searching for drugs that can shrink those waistlines again. (livescience.com)
  • The administrator wanted to tell us how a clinical team recently utilized the Nebraska Prescription Drug Monitoring Program (PDMP) and potentially saved a local patient's life. (himss.org)
  • This patient's husband was concerned about the rate at which she was refilling her prescriptions. (himss.org)
  • The nurse he spoke to made sure the physician consulted the PDMP during the next patient visit, and he saw some troubling activity with the patient's prescriptions for controlled substances. (himss.org)
  • In the example I shared here, the clinical team cared about the patient and wanted to utilize clinical tools to monitor the patient's prescriptions in order to ensure the best care possible. (himss.org)
Drug Prescriptions | Profiles RNS
Drug Prescriptions | Profiles RNS (profiles.umassmed.edu)
Many Drug Prescriptions Go Unfilled - The New York Times
Many Drug Prescriptions Go Unfilled - The New York Times (well.blogs.nytimes.com)
Deputies: Whitestown Family Arrested in Prescription Drug Bust with Fentanyl | WSTM
Deputies: Whitestown Family Arrested in Prescription Drug Bust with Fentanyl | WSTM (cnycentral.com)
Prescription drug case: Rand to remain in custody; argument heard for West's release | KRNV
Prescription drug case: Rand to remain in custody; argument heard for West's release | KRNV (mynews4.com)
Gender differences among Swedish COPD patients: results from the ARCTIC, a real-world retrospective cohort study | npj Primary...
Gender differences among Swedish COPD patients: results from the ARCTIC, a real-world retrospective cohort study | npj Primary... (nature.com)
CDC - 2013 Prevention Status Reports (PSR) - Prescription Drug Overdose - STLT Gateway
CDC - 2013 Prevention Status Reports (PSR) - Prescription Drug Overdose - STLT Gateway (cdc.gov)
Drug use in children: cohort study in three European countries | The BMJ
Drug use in children: cohort study in three European countries | The BMJ (bmj.com)
Prescription Drug Overdose Prevention | NIOSH | CDC
Prescription Drug Overdose Prevention | NIOSH | CDC (cdc.gov)
Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic...
Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic... (nature.com)
State Prescription Drug Laws  | Drug Overdose | CDC Injury Center
State Prescription Drug Laws | Drug Overdose | CDC Injury Center (cdc.gov)
U.S. GAO - Speeding Up the Drug Review Process: Results Encouraging but Progress Slow
U.S. GAO - Speeding Up the Drug Review Process: Results Encouraging but Progress Slow (gao.gov)
License of Illinois psychiatrist suspended - Chicago Tribune
License of Illinois psychiatrist suspended - Chicago Tribune (chicagotribune.com)
CDC - Prescription Drugs - Publications and Resources - Public Health Law
CDC - Prescription Drugs - Publications and Resources - Public Health Law (cdc.gov)
Health Information in Nepali (नेपाली): MedlinePlus
Health Information in Nepali (नेपाली): MedlinePlus (medlineplus.gov)
AARP NY's End of Legislative Session Review
AARP NY's End of Legislative Session Review (aarp.org)
Prescription Drug Abuse, Jul 26 2006 | Video | C-SPAN.org
Prescription Drug Abuse, Jul 26 2006 | Video | C-SPAN.org (c-span.org)
CDC - Grantee Highlights - Arkansas - Blocking Prescription Drug Abuse - Block Grant (PHHSBG)
CDC - Grantee Highlights - Arkansas - Blocking Prescription Drug Abuse - Block Grant (PHHSBG) (cdc.gov)
Prescription Drug Monitoring Programs (PDMPs)  | Drug Overdose | CDC Injury Center
Prescription Drug Monitoring Programs (PDMPs) | Drug Overdose | CDC Injury Center (cdc.gov)
Suicidal ideation - Wikipedia
Suicidal ideation - Wikipedia (en.wikipedia.org)
Patients Curb Prescription Spending - WSJ
Patients Curb Prescription Spending - WSJ (wsj.com)
8 ways Colorado lawmakers want to make health care cheaper
8 ways Colorado lawmakers want to make health care cheaper (denverpost.com)
U.S. GAO - Maternal Mortality: Trends in Pregnancy-Related Deaths and Federal Efforts to Reduce Them
U.S. GAO - Maternal Mortality: Trends in Pregnancy-Related Deaths and Federal Efforts to Reduce Them (gao.gov)
2019 Prescription Drug Survey
2019 Prescription Drug Survey (aarp.org)
Creon Dosage Guide - Drugs.com
Creon Dosage Guide - Drugs.com (drugs.com)
Apri - FDA prescribing information, side effects and uses
Apri - FDA prescribing information, side effects and uses (drugs.com)
Sotalol Hydrochloride AF Side Effects: Common, Severe, Long Term - Drugs.com
Sotalol Hydrochloride AF Side Effects: Common, Severe, Long Term - Drugs.com (drugs.com)
Kenalog Cream - FDA prescribing information, side effects and uses
Kenalog Cream - FDA prescribing information, side effects and uses (drugs.com)
E.E.S, 400 Tablets - FDA prescribing information, side effects and uses
E.E.S, 400 Tablets - FDA prescribing information, side effects and uses (drugs.com)
Pexeva Dosage Guide - Drugs.com
Pexeva Dosage Guide - Drugs.com (drugs.com)
Pravachol User Reviews for Revascularization Procedures, Prophylaxis at Drugs.com
Pravachol User Reviews for Revascularization Procedures, Prophylaxis at Drugs.com (drugs.com)